Yan, Y., Ma, J., Wang, D., Lin, D., Pang, X., Wang, S., . . . Huang, H. (2019). The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer. EMBO Mol Med.

Yan, Yuqian, et al. "The Novel BET‐CBP/p300 Dual Inhibitor NEO2734 Is Active in SPOP Mutant and Wild‐type Prostate Cancer." EMBO Mol Med 2019.

Yan, Yuqian, et al. "The Novel BET‐CBP/p300 Dual Inhibitor NEO2734 Is Active in SPOP Mutant and Wild‐type Prostate Cancer." EMBO Mol Med 2019.